Reason for request
Re-assessment of the actual benefit at the request of the Transparency
Clinical Benefit
| Low |
Le service médical rendu par MEGACE 160 mg est faible dans le traitement palliatif des carcinomes du sein.
|
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
UxPsBeTeP5xawNZE
Listen
